QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                         What's this?

Oligodendrocyte differentiation from ES cells

Oligodendrocytes develop from neuroepithelial cells and myelinate axons in the CNS. Our understanding of their development is limited, since quantities sufficient for biochemical analyses cannot be purified and the stem cells from which they originate have not been isolated. To get around this problem, Nathalie Billon and co-workers have developed a method for generating oligodendrocytes in vitro (see p. 3657). They engineered ES cells to express drug-resistance/susceptibility genes from promoters active in neuroepithelial cells (ßgeo-Sox2) and undifferentiated ES cells (tk-Oct4) and used the drugs (G418 and Ganciclovir) to select for neuroepithelial cells and eliminate undifferentiated ES cells, respectively; they then exposed the cells to signals known to promote oligodendrocyte differentiation (FGF-2, Sonic Hedgehog, PDGF-AA and thyroid hormone). Under these conditions, the cells followed the developmental pathway observed in vivo, adopting the correct morphology and expressing appropriate markers (Olig2, PDGFR, NG2 proteoglycan and galactocerebroside) at the correct times. The technique indicates that an important developmental lineage can be reconstituted entirely from ES cells. Moreover, it could be adapted to produce human cells and thus be used in treatment of demyelinating diseases such as multiple sclerosis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in JCS:

Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells

Nathalie Billon, Christine Jolicoeur, Qi Long Ying, Austin Smith, and Martin Raff
JCS 2002 115: 3657-3665. [Abstract] [Full Text]  

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                         What's this?